Anand Shuchi, Kondal Dimple, Montez-Rath Maria, Zheng Yuanchao, Shivashankar Roopa, Singh Kalpana, Gupta Priti, Gupta Ruby, Ajay Vamadevan S, Mohan Viswanathan, Pradeepa Rajendra, Tandon Nikhil, Ali Mohammed K, Narayan K M Venkat, Chertow Glenn M, Kandula Namratha, Prabhakaran Dorairaj, Kanaya Alka M
Centre for Chronic Conditions and Injuries, Public Health Foundation of India, New Delhi, India.
Centre for Chronic Disease Control, New Delhi, India.
PLoS One. 2017 Mar 15;12(3):e0173554. doi: 10.1371/journal.pone.0173554. eCollection 2017.
While data from the latter part of the twentieth century consistently showed that immigrants to high-income countries faced higher cardio-metabolic risk than their counterparts in low- and middle-income countries, urbanization and associated lifestyle changes may be changing these patterns, even for conditions considered to be advanced manifestations of cardio-metabolic disease (e.g., chronic kidney disease [CKD]).
Using cross-sectional data from the Center for cArdiometabolic Risk Reduction in South Asia (CARRS, n = 5294) and Mediators of Atherosclerosis in South Asians Living in America (MASALA, n = 748) studies, we investigated whether prevalence of CKD is similar among Indians living in Indian and U.S. cities. We compared crude, age-, waist-to-height ratio-, and diabetes- adjusted CKD prevalence difference. Among participants identified to have CKD, we compared management of risk factors for its progression. Overall age-adjusted prevalence of CKD was similar in MASALA (14.0% [95% CI 11.8-16.3]) compared with CARRS (10.8% [95% CI 10.0-11.6]). Among men the prevalence difference was low (prevalence difference 1.8 [95% CI -1.6,5.3]) and remained low after adjustment for age, waist-to-height ratio, and diabetes status (-0.4 [-3.2,2.5]). Adjusted prevalence difference was higher among women (prevalence difference 8.9 [4.8,12.9]), but driven entirely by a higher prevalence of albuminuria among women in MASALA. Severity of CKD--i.e., degree of albuminuria and proportion of participants with reduced glomerular filtration fraction--was higher in CARRS for both men and women. Fewer participants with CKD in CARRS were effectively treated. 4% of CARRS versus 51% of MASALA participants with CKD had A1c < 7%; and 7% of CARRS versus 59% of MASALA participants blood pressure < 140/90 mmHg. Our analysis applies only to urban populations. Demographic--particularly educational attainment--differences among participants in the two studies are a potential source of bias.
Prevalence of CKD among Indians living in Indian and U.S. cities is similar. Persons with CKD living in Indian cities face higher likelihood of experiencing end-stage renal disease since they have more severe kidney disease and little evidence of risk factor management.
20世纪后期的数据一直表明,与低收入和中等收入国家的人群相比,高收入国家的移民面临更高的心血管代谢风险。然而,城市化及相关生活方式的改变可能正在改变这些模式,即使是对于被视为心血管代谢疾病晚期表现的病症(如慢性肾脏病[CKD])。
利用来自南亚心血管代谢风险降低中心(CARRS,n = 5294)和美国南亚人动脉粥样硬化中介因素(MASALA,n = 748)研究的横断面数据,我们调查了生活在印度和美国城市的印度人之间CKD患病率是否相似。我们比较了粗患病率、年龄调整患病率、腰高比调整患病率和糖尿病调整患病率的差异。在被确定患有CKD的参与者中,我们比较了其疾病进展危险因素的管理情况。与CARRS(10.8%[95%CI 10.0 - 11.6])相比,MASALA中CKD的总体年龄调整患病率相似(14.0%[95%CI 11.8 - 16.3])。在男性中,患病率差异较低(患病率差异1.8[95%CI - 1.6,5.3]),在调整年龄、腰高比和糖尿病状态后仍较低(-0.4[-3.2,2.5])。女性的调整患病率差异较高(患病率差异8.9[4.8,12.9]),但完全是由MASALA中女性白蛋白尿患病率较高所致。在CARRS中,男性和女性的CKD严重程度(即白蛋白尿程度和肾小球滤过率降低的参与者比例)均较高。CARRS中患有CKD的参与者接受有效治疗的较少。CARRS中4%的CKD参与者与MASALA中51%的CKD参与者糖化血红蛋白(A1c)<7%;CARRS中7%的CKD参与者与MASALA中59%的CKD参与者血压<140/90 mmHg。我们的分析仅适用于城市人口。两项研究参与者之间的人口统计学差异(尤其是教育程度差异)是潜在的偏差来源。
生活在印度和美国城市的印度人之间CKD患病率相似。生活在印度城市患有CKD的人面临更高的进入终末期肾病的可能性,因为他们的肾脏疾病更严重,且几乎没有危险因素管理的证据。